Browsing Tag
CAMP4 Therapeutics Corporation
1 post
CMP-002 trial clearance unlocks $50m as CAMP4 enters first-in-human stage
CAMP4 unlocks up to $50 million after Australian clearance for its CMP-002 trial, strengthening runway while creating major dilution.